Iskandar M, Xiao Barbero M, Jaber M, Chen R, Gomez-Guevara R, Cruz E
Cancers (Basel). 2025; 17(2).
PMID: 39858038
PMC: 11764024.
DOI: 10.3390/cancers17020257.
Shitova M, Alpeeva E, Vorotelyak E
Int J Mol Sci. 2024; 25(23).
PMID: 39684765
PMC: 11641324.
DOI: 10.3390/ijms252313054.
Balzanelli M, Rastmanesh R, Distratis P, Lazzaro R, Inchingolo F, Del Prete R
Endocr Metab Immune Disord Drug Targets. 2024; 25(2):85-98.
PMID: 38468535
DOI: 10.2174/0118715303283480240227113401.
Xian S, Dosset M, Castro A, Carter H, Zanetti M
PNAS Nexus. 2023; 2(3):pgad046.
PMID: 36909826
PMC: 10003760.
DOI: 10.1093/pnasnexus/pgad046.
Klotz K, Radwan Y, Chakrabarti K
Molecules. 2023; 28(1).
PMID: 36615420
PMC: 9821959.
DOI: 10.3390/molecules28010228.
RNA-guided DNA base damage repair via DNA polymerase-mediated nick translation.
Tsegay P, Hernandez D, Qu F, Olatunji M, Mamun Y, Chapagain P
Nucleic Acids Res. 2022; 51(1):166-181.
PMID: 36533524
PMC: 9841414.
DOI: 10.1093/nar/gkac1178.
Establishment and Characterization of Immortalized Hutchinson-Gilford Progeria Fibroblast Cell Lines.
Lin H, Mensch J, Haschke M, Jager K, Kottgen B, Dernedde J
Cells. 2022; 11(18).
PMID: 36139359
PMC: 9497314.
DOI: 10.3390/cells11182784.
The Structural, Functional and Evolutionary Impact of Transposable Elements in Eukaryotes.
Almojil D, Bourgeois Y, Falis M, Hariyani I, Wilcox J, Boissinot S
Genes (Basel). 2021; 12(6).
PMID: 34203645
PMC: 8232201.
DOI: 10.3390/genes12060918.
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy.
Eckburg A, Dein J, Berei J, Schrank Z, Puri N
Cancers (Basel). 2020; 12(9).
PMID: 32825005
PMC: 7565511.
DOI: 10.3390/cancers12092337.
Transposable elements in .
Merel V, Boulesteix M, Fablet M, Vieira C
Mob DNA. 2020; 11:23.
PMID: 32636946
PMC: 7334843.
DOI: 10.1186/s13100-020-00213-z.
Telomerase and CD4 T Cell Immunity in Cancer.
Dosset M, Castro A, Carter H, Zanetti M
Cancers (Basel). 2020; 12(6).
PMID: 32630460
PMC: 7352225.
DOI: 10.3390/cancers12061687.
Emerging roles of telomeric chromatin alterations in cancer.
Cacchione S, Biroccio A, Rizzo A
J Exp Clin Cancer Res. 2019; 38(1):21.
PMID: 30654820
PMC: 6337846.
DOI: 10.1186/s13046-019-1030-5.
Suppressive Effects of EGCG on Cervical Cancer.
Wang Y, Lu J, Liang Y, Li Q
Molecules. 2018; 23(9).
PMID: 30213130
PMC: 6225117.
DOI: 10.3390/molecules23092334.
Telomerase Reverse Transcriptase Contains a BH3-Like Motif and Interacts with BCL-2 Family Members.
Jin Y, You L, Kim H, Lee H
Mol Cells. 2018; 41(7):684-694.
PMID: 29937479
PMC: 6078858.
DOI: 10.14348/molcells.2018.0206.
Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
El Hajj J, Nguyen E, Liu Q, Bouyer C, Adriaenssens E, Hilal G
Mol Cancer. 2018; 17(1):85.
PMID: 29703210
PMC: 5923027.
DOI: 10.1186/s12943-018-0835-8.
The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.
Schimmel P
Nat Rev Mol Cell Biol. 2017; 19(1):45-58.
PMID: 28875994
DOI: 10.1038/nrm.2017.77.
Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.
Wang H, Zhou J, He Q, Dong Y, Liu Y
Mol Med Rep. 2017; 15(6):4055-4060.
PMID: 28487971
PMC: 5436214.
DOI: 10.3892/mmr.2017.6549.
Genistein suppresses the proliferation of telomerase-negative cells.
Lin C, Hsieh M, Teng S
Food Sci Nutr. 2017; 5(2):197-204.
PMID: 28265354
PMC: 5332266.
DOI: 10.1002/fsn3.382.
An evolutionary balance: conservation vs innovation in ciliate membrane trafficking.
Guerrier S, Plattner H, Richardson E, Dacks J, Turkewitz A
Traffic. 2016; 18(1):18-28.
PMID: 27696651
PMC: 5182178.
DOI: 10.1111/tra.12450.
Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
Hu Y, Shi G, Zhang L, Li F, Jiang Y, Jiang S
Sci Rep. 2016; 6:32280.
PMID: 27578458
PMC: 5006076.
DOI: 10.1038/srep32280.
